Skip to main content

ADVERTISEMENT

Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA, MSc, FFPM, RCPS(Glasg)

Review
07/07/2022
This publication, the first in a series, provides an evidence basis of the gap between definition and treatment of complex wounds, an overview of the use of autologous therapies in these wounds, and the science behind TABCT.
This publication, the first in a series, provides an evidence basis of the gap between definition and treatment of complex wounds, an overview of the use of autologous therapies in these wounds, and the science behind TABCT.
This publication, the first in a...
07/07/2022
Wounds
Preview Image
Videos
10/06/2022
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
In this interview, Dr. Robert J....
10/06/2022
Wounds
Preview Image
Videos
10/06/2022
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
In this research presentation,...
10/06/2022
Wounds
Case Series
08/01/2018
Two cases are presented that demonstrate the paradigmatic clinical features of PASH syndrome and its potential link as an expanding spectrum of bacterial biofilm disorder.
Two cases are presented that demonstrate the paradigmatic clinical features of PASH syndrome and its potential link as an expanding spectrum of bacterial biofilm disorder.
Two cases are presented that...
08/01/2018
Wounds
Original Research
12/20/2023
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
This study examines the efficacy...
12/20/2023
Wounds
Author Insights
01/10/2024
Dr. Robert Snyder shares key details from his original research paper, “An Open-label, Proof of Concept Study, Assessing the Effects of Bromelain-Based Enzymatic Debridement on Biofilm and Microbial Loads in Patients with Venous Leg and...
Dr. Robert Snyder shares key details from his original research paper, “An Open-label, Proof of Concept Study, Assessing the Effects of Bromelain-Based Enzymatic Debridement on Biofilm and Microbial Loads in Patients with Venous Leg and...
Dr. Robert Snyder shares key...
01/10/2024
Wounds